Explaining phenotype heterogeneity in patients with psoriasis.

Explaining phenotype heterogeneity in patients with psoriasis.

Item
http://www.wikidata.org/entity/Q37019141
Comparison of the Expression Profile of JunB, c-Jun, and S100A8 (Calgranulin A) in Psoriasis Vulgaris and Guttate PsoriasisSerum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis.Expression of interleukin-17 is correlated with interferon-α expression in cutaneous lesions of lupus erythematosus.Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility.Antimicrobial peptide LL-37 along with peptidoglycan drive monocyte polarization toward CD14(high)CD16(+) subset and may play a crucial role in the pathogenesis of psoriasis guttataMolecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets.Five-year experience with infliximab: Follow up of the product familiarisation program.Gene Expression Analysis of Inflammatory Cytokines in Korean Psoriatic Patients.Tissue and Serum Inflammatory Cytokine Levels in Korean Psoriasis Patients: A Comparison between Plaque and Guttate PsoriasisIL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.A comparison of serum inflammatory cytokines according to phenotype in patients with psoriasis.IL-17A, IL-22, and IL-23 as Markers of Psoriasis Activity: A Cross-sectional, Hospital-based Study.The effect of adalimumab on key drivers in the pathogenesis of psoriasis.
P2860

Explaining phenotype heterogeneity in patients with psoriasis.

Item
http://www.wikidata.org/entity/Q37019141
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Explaining phenotype heterogeneity in patients with psoriasis.
@en
Explaining phenotype heterogeneity in patients with psoriasis.
@nl
type
label
Explaining phenotype heterogeneity in patients with psoriasis.
@en
Explaining phenotype heterogeneity in patients with psoriasis.
@nl
prefLabel
Explaining phenotype heterogeneity in patients with psoriasis.
@en
Explaining phenotype heterogeneity in patients with psoriasis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Explaining phenotype heterogeneity in patients with psoriasis.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2133.2007.08307.X
P407
P433
P478
P577
P698